Clinical Trial Update: Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluating a modified diagnosis and treatment approach for neonatal hyperbilirubinemia using ETCOc; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperbilirubinemia

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Neonatal Hyperbilirubinemia | EARLY_Phase 1 | Status: RECRUITING